Start the conversation
The Dow Jones today can pop higher after the Trump administration announced plans to fast-track a potential groundbreaking treatment for COVID-19.
Apple Inc. (NASDAQ: AAPL) continues to rally. Read on for more stocks and events pushing the Dow today.
We'll start with the numbers from Friday for the Dow, S&P 500, and Nasdaq:
|Index||Previous Close||Point Change||Percentage Change|
Now here are what I think will be the most important market events and stocks on Monday morning.
The Top Stock Market Stories for Monday
- This morning, Johns Hopkins University reported that the number of U.S. COVID-19 cases reached 5.7 million. Deaths topped out just under 177,000. The World Health Organization said that 172 countries are now engaged with the agency to rollout a globally coordinated effort to deploy a vaccine. Meanwhile, in the United States, the number of COVID-19 cases has declined over the last week. The nation reported just 44,000 cases on Thursday, which was an 11% drop from the previous seven-day average.
Three stocks every investor should consider owning today - and dozens of stocks to drop immediately. Click here...
- U.S. President Donald Trump has granted an emergency authorization for a coronavirus plasma treatment that could potentially boost antibodies against the virus. The treatment will use the blood of previous COVID-19 patients who have recovered and infuse it into others to prevent the disease. Despite the announcement, critics have expressed some concerns about the lack of clinical data to support the treatment as a viable mass treatment.
- Finally, oil prices are in focus as two major storms threaten the refinery network of the United States. Roughly 50% of America's refineries exist on the Gulf Coast. This week, two major storms - Marco and Laura - are expected to make landfall. The threat of two back-to-back hurricanes is a reminder of Hurricane Katrina, which struck 15 years ago and caused immense damage to Louisiana.
Stocks to Watch Today: AAPL, BX, MRNA, AZN
- Shares of Apple Inc. (NASDAQ: AAPL) added another 3%, and shares topped $513. The stock had jumped another 8% last week ahead of the company's planned stock split. Apple will split its stock 4-for-1 for shareholders of record after Monday's closing bell. Shares will trade on a split-adjusted basis starting next week.
- In deal news, Blackstone Group Inc. (NYSE: BX) announced plans to purchase the consumer healthcare division of the Japanese firm Takeda Pharmaceutical. Reports state that the private equity giant will spend roughly $2.3 billion on the deal.
- Moderna Inc. (NASDAQ: MRNA) announced that enrollment for its 30,000-patient late-stage trial for a COVID-19 cure has topped the 40% mark. The company launched its study in July and plans to wrap up by September. Meanwhile, AstraZeneca Plc. (NYSE: AZN) could see its vaccine candidate with Oxford University receive fast-tracking approval. According to the Financial Times, the White House is considering a plan that would see the U.S. Food and Drug Administration give the company an emergency authorization.
BUY THIS, NOT THAT: the Best (and Worst) Stocks in America
Money Morning's brand-new chief investment strategist is going live in his first-ever segment of BUY THIS, NOT THAT.
In 30 minutes or less, Shah Gilani is going to run through all 50+ stocks you should know about - for better or for worse.
Shah is not holding back; prices, tickers, and company names will be coming your way fast.
Be ready to take notes! Watch now...
About the Author
Garrett Baldwin is a globally recognized research economist, financial writer, and consultant with degrees from Northwestern, Johns Hopkins, Purdue, and Indiana University. He is a seasoned financial and political risk analyst, with a focus on stocks, hedge funds, private equity, blockchain, and housing policy. He has conducted risk assessment projects for clients in 27 countries, and consulted on policy and financial operations for some of the nation's largest financial institutions, including a $1.5 trillion credit fund, a $43 billion credit and auto loan giant, as well as two of the largest Wall Street banks by assets under management.
Garrett joined Money Map Press as an economist and researcher in 2011, specializing in alternative strategies with an emphasis on fundamental and technical analysis.